HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency - report from ESC2023

from Medical Digest & Congress Report · host Medical Congress News

Professor Robert Mentz provides a summary of the HEART-FID trial. The study investigated the long-term safety and efficacy of supplementing heart failure patients with iv iron. There was no significant difference between ferric carboxymaltose and placebo in the primary composite outcome, including death, heart failure hospitalizations, and a six-minute walk distance. Video: https://medicaldigest.org/scientific-contents/interview:heart-fid-ferric-carboxymaltose-heart-failure-iron-deficiency

Episode metadata supplied by the publisher feed · Published Sep 7, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency - report from ESC2023

0:00 5:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on September 7, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!